HDL biogenesis and cellular cholesterol homeostasis

Annals of Medicine

Volumn 40, Issue SUPPL. 1, 2008, Pages 29-38

  Yokoyama, Shinji ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

ABC; Apolipoprotein; Caveolin; Cholesterol efflux; HDL; Membrane

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN; BILE ACID; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; MONOCLONAL ANTIBODY; PHOSPHOLIPID;

ATHEROSCLEROSIS; BIOGENESIS; CATABOLISM; CELL ACTIVITY; CELL INTERACTION; CELL TRANSPORT; CHOLESTEROL TRANSPORT; CONFERENCE PAPER; HOMEOSTASIS; NONHUMAN; PRIORITY JOURNAL;

EID: 38849168858     PISSN: 07853890     EISSN: 16512219     Source Type: Journal    
DOI: 10.1080/07853890701727429     Document Type: Conference Paper

References (69)

1. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34-47.
2. Brown MS, Goldstein JL. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A. 1999;96:11041-8.
3. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109:1125-31.
4. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995;36:211-28.
5. Gordon DJ, Rifkind BM. High density lipoprotein - The clinical implications of recent studies. New Eng J Med. 1989;321:1311-6.
6. Ho YK, Brown MS, Goldstein JL. Hydrolysis and excretion of cytoplasmic cholesterol esters by macrophages: Stimulation by high density lipoprotein and other agents. J Lipid Res. 1980;21:391-8.
7. Oram JF, Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res. 1996;37:2473-91.
8. Yokoyama S. Apolipoprotein-mediated cellular cholesterol efflux. Biochim Biophys Acta. 1998;1392:1-15.
9. Yokoyama S. Release of cellular cholesterol: Molecular mechanism for cholesterol homeostasis in cells and in the body. Biochim Biophys Acta. 2000;1529:231-44.
10. Glomset JA. The lecithin: cholesterol acyltransferase reaction. J Lipid Res. 1968;9:155-67.
11. Czarnecka H, Yokoyama S. Lecithin: cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. Biochemistry. 1995;34:4385-92.
12. Czarnecka H, Yokoyama S. Regulation of cellular cholesterol efflux by lecithin: cholesterol acyltransferase reaction through nonspecific lipid exchange. J Biol Chem. 1996;271:2023-8.
13. Ji Y, Jian B, Wang N, Sun Y, Moya ML, Phillips MC, et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem. 1997;272:20982-5.
14. de La Llera-Moya M, Connelly MA, Drazul D, Klein SM, Favari E, Yancey PG, et al. Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL. J Lipid Res. 2001;42:1969-78.
15. Liu T, Krieger M, Kan HY, Zannis VI. The effects of mutations in helices 4 and 6 of ApoA-I on scavenger receptor class B type I (SR-BI)-mediated cholesterol efflux suggest that formation of a productive complex between reconstituted high density lipoprotein and SR-BI is required for efficient lipid transport. J Biol Chem. 2002;277:21576-84.
16. Chroni A, Nieland TJ, Kypreos KE, Krieger M, Zannis VI. SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux. Biochemistry. 2005;44:13132-43.
17. Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A. 2004;101:9774-9.
18. Hara H, Yokoyama S. Interaction of free apolipoprotein with macrophages: Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J Biol Chem. 1991;266:3080-6.
19. Forte TM, Goth-Goldstein R, Nordhausen RW, McCall MR. Apolipoprotein A-I-cell membrane interaction: extracellular assembly of heterogeneous nascent HDL particles. J Lipid Res. 1993;34:317-24.
20. Forte TM, Bielicki JK, Knoff L, McCall MR. Structural relationships between nascent apoA-I-containing particles that are extracellularly assembled in cell culture. J Lipid Res. 1996;37:1076-85.
21. Forte TM, Bielicki JK, Goth-Goldstein R, Selmek J, McCall MR. Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J Lipid Res. 1995;36:148-57.
22. Hara H, Hara H, Komaba A, Yokoyama S. α-Helical requirements for free apolipoproteins to generate HDL and to induce cellular lipid efflux. Lipids. 1992;27:302-4.
23. Yancey PG, Bielicki JK, Johnson WJ, Lund-Katz S, Palgunachari MN, Anantharamaiah GM, et al. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry. 1995;34:7955-65.
24. Mendez AJ, Anantharamaiah GM, Segrest JP, Oram JF. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J Clin Invest. 1994;94:1698-705.
25. Remaley AT, Thomas F, Stonik JA, Demosky SJ, Bark SE, Neufeld EB, et al. Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway. J Lipid Res. 2003;44:828-36.
26. Francis GA, Knopp RH, Oram JF. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest. 1995;96:78-87.
27. Remaley AT, Schumacher UK, Stonik JA, Farsi BD, Nazih HB, Brewer HBJ. Decreased reverse cholesterol transport from Tangier disease fibroblasts: Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler Thromb Vasc Biol. 1997;17:1813-21.
28. Brooks-Wilson A, Marcil M, Clee SM, Zhang L-H, Roomp K, van Dam M, et al. Mutations in ABC1 in tangier disease and familial high-density lipoprotein deficiency. Nat Genet. 1999;22:336-45.
29. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederrich W, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet. 1999;22:347-51.
30. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette J-C, et al. Tangier disease is caused by mutations in the gene encoding ATP binding-cassette transporter 1. Nat Genet. 1999;22:352-5.
31. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest. 1999;104:R25-R31.
32. Remaley AT, Rust S, Rosier M, Knapper C, Naudin L, Broccardo C, et al. Human ATP-binding cassette transporter 1 (ABC1): Genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc Natl Acad Sci U S A. 1999;96:12685-90.
33. Marcil M, Brooks-Wilson A, Clee SM, Roomp K, Zhang LH, Yu L, et al. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet. 1999;354:1341-6.
34. Orso E, Broccardo C, Kaminski WE, Böttcher A, Liebisch G, Drobnik W, et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and abc1-deficient mice. Nat Genet. 2000;24:192-6.
35. McNeish J, Aiello RJ, Guyot D, Turi T, Gabel C, Aldinger C, et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci U S A. 2000;97:4245-50.
36. Abe-Dohmae S, Suzuki S, Wada Y, Aburatani H, Vance DE, Yokoyama S. Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line. Biochemistry. 2000;39:11092-9.
37. Oram JF, Lawn RM, Garvin MR, Wade DP. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem. 2000;275:34508-11.
38. Tajima S, Yokoyama S, Yamamoto A. Effect of lipid particle size on association of apolipoproteins with lipid. J Biol Chem. 1983;258:10073-82.
39. Okabe H, Yokoyama S, Yamamoto A. Modulation of cholesterol microenvironment with apolipoproteins induced by the presence of cholesteryl ester in lipid microemulsion. J Biochem. 1988;104:141-8.
40. Liang H-Q, Rye K-A, Barter PJ. Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins. J Lipid Res. 1994;35:1187-99.
41. Liang H-Q, Rye K-A, Barter PJ. Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools. Biochim Biophys Acta. 1995;1257:31-7.
42. Clay MA, Newnham HH, Forte TM, Barter PI. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta. 1992;1124:52-8.
43. Pussinen P, Jauhiainen M, Metso J, Tyynela J, Ehnholm C. Pig plasma phospholipid transfer protein facilitates HDL interconversion. J Lipid Res. 1995;36:975-85.
44. Wolfbauer G, Albers JJ, Oram JF. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim Biophys Acta. 1999;1439:65-76.
45. Komaba A, Li Q, Hara H, Yokoyama S. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol. J Biol Chem. 1992;267:17560-6.
46. Okuhira K, Tsujita M, Yamauchi Y, Abe-Dohmae S, Kato K, Handa T, et al. Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL. J Lipid Res. 2004;45:645-52.
47. Bell-Quint J, Forte T. Time-related changes in the synthesis and secretion of very low density, low density and high density lipoproteins by cultured rat hepatocytes. Biochim Biophys Acta. 1981;663:83-98.
48. Cheung MC, Lum KD, Brouillette CG, Bisgaier CL. Characterization of apoA-I-containing lipoprotein subpopulations secreted by HepG2 cells. J Lipid Res. 1989;30:1429-36.
49. Sorci-Thomas M, Prack MM, Dashti N, Johnson F, Rudel LL, Williams DL. Apolipoprotein (apo) A-I production and mRNA abundance explain plasma apoA-I and high density lipoprotein differences between two nonhuman primate species with high and low susceptibilities to diet-induced hypercholesterolemia. J Biol Chem. 1988;263:5183-9.
50. Sorci-Thomas M, Prack MM, Dashti N, Johnson F, Rudel LL, Williams DL. Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density lipoproteins. J Lipid Res. 1989;30:1397-403.
51. Smith JD, Miyata M, Ginsberg M, Grigaux C, Shmookler E, Plump AS. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from macrophage cell line to apolipoprotein acceptors. J Biol Chem. 1996;271:30647-55.
52. Zhang W-Y, Gaynor PM, Kruth HS. Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J Biol Chem. 1996;271:28641-6.
53. Tsujita M, Wu C-A, Abe-Dohmae S, Usui S, Okazaki M, Yokoyama S. On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway. J Lipid Res. 2005;46:154-62.
54. Chisholm JW, Burleson ER, Shelness GS, Parks JS. ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL. J Lipid Res. 2002;43:36-44.
55. Kiss RS, McManus DC, Franklin V, Tan WL, McKenzie A, Chimini G, et al. The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways. J Biol Chem. 2003;278:10119-27.
56. Ito J, Zhang L, Asai M, Yokoyama S. Differential generation of high-density lipoprotein by endogenous and exogenous apolipoproteins in cultured fetal rat astrocytes. J Neurochem. 1999;72:2362-9.
57. Li Q, Komaba A, Yokoyama S. Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells. Biochemistry. 1993;32:4597-603.
58. Jonas A. Reconstitution of high-density lipoproteins. Methods Enzymol. 1986;128:553-82.
59. von Eckardstein A, Assmann G. High density lipoproteins and reverse cholesterol transport: lessons from mutations. Atherosclerosis. 1998;137:S7-11.
60. Nanjee MN, Cooke CJ, Olszewski WL, Miller NE. Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph. Arterioscler Thromb Vasc Biol. 2000;20:2148-55.
61. Abe-Dohmae S, Ikeda Y, Matsuo M, Hayashi M, Okuhira K, Ueda K, et al. Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. J Biol Chem. 2004;279:604-11.
62. Wang N, Lan D, Gerbod-Giannone M, Linsel-Nitschke P, Jehle AW, Chen W, et al. ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux. J Biol Chem. 2003;278:42906-12.
63. Hayashi M, Abe-Dohmae S, Okazaki M, Ueda K, Yokoyama S. Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7. J Lipid Res. 2005;46:1703-11.
64. Abe-Dohmae S, Kato KH, Kumon Y, Hu W, Ishigami H, Iwamoto N, et al. Serum amyloid A generates high density lipoprotein with cellular lipid in an ABCA1- or ABCA7-dependent manner. J Lipid Res. 2006;7:1542-50.
65. Kim WS, Fitzgerald ML, Kang K, Okuhira K, Bell SA, Manning JJ, et al. ABCA7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels. J Biol Chem. 2005;280:3989-95.
66. Iwamoto N, Abe-Dohmae S, Sato R, Yokoyama S. ABCA7 expression is regulated by cellular cholesterol through the SREBP2 pathway and associated with phagocytosis. J Lipid Res. 2006;47:1915-27.
67. Assmann G, von Eckardstein A, Brewer HB Jr. Familial Analphalipoproteinemia: Tangier Disease. In: Scriver CR, Beaudet AL, Valle D, Sly WS, Scriver CR, Beaudet AL, et al. The Metabolic and Molecular Basis of Inherited Disease. 8th ed. New York: McGraw-Hill, 2001. p. 2937-60.
68. Glomset JA, Assmann G, Gjone E, Norum KR. Lecithin: cholesterol acyltransferase deficiency and fish eye disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Scriver CR, Beaudet AL, et al. The Metabolic and Molecular Basis of Inherited Disease. 7th ed. New York: McGraw-Hill, Inc. Health Profession Division, 1995. p. 1933-52.
69. Tomimoto S, Tsujita M, Okazaki M, Usui S, Tada T, Fukutomi T, et al. Effect of probucol in lecithin-cholesterol acyltransferase deficient mice: Inhibition of two independent cellular cholesterol releasing pathways in vivo. Arterioscler Thromb Vasc Biol. 2001;21:394-400.